Literature DB >> 6531796

Morbidity following prophylactic and therapeutic lymph node dissection for melanoma--a comparison.

C Ingvar, C Erichsen, P E Jönsson.   

Abstract

Between 1976 and 1982, 110 isolated regional lymph node dissections (RLND) for melanoma were performed as a prophylactic procedure (PLND) in 44 and therapeutic procedure (TLND) in 64 patients. The prevalence of metastases was 20% in the PLND group. The number of patients with complications in the PLND were 17/44 (39%) and in the TLND 39/64 (61%). Local wound complications dominated. Serum collections occurred in 25% of PLND patients and 45% of TLND patients (p less than 0.05), and infections, skin necrosis, and cellulitis in respectively 11% and 22%. The incidence of lymphedema was 10% in PLND and 23% in TLND patients. Regarding the anatomic sites, there were significantly more seromas after axillary dissection in TLND patients compared with PLND patients (p less than 0.05). However, no difference was observed between groin dissections in the 2 groups. The socioeconomic effects in terms of hospital stay and further therapeutic measures were pronounced when complications occurred.

Entities:  

Mesh:

Year:  1984        PMID: 6531796     DOI: 10.1177/030089168407000610

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  8 in total

1.  Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.

Authors:  Sharon B Chang; Robert L Askew; Yan Xing; Storm Weaver; Jeffrey E Gershenwald; Jeffrey E Lee; Richard Royal; Anthony Lucci; Merrick I Ross; Janice N Cormier
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

2.  Weight lifting in patients with lower-extremity lymphedema secondary to cancer: a pilot and feasibility study.

Authors:  Elana Katz; Nicole L Dugan; Joy C Cohn; Christina Chu; Rebecca G Smith; Kathryn H Schmitz
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

3.  The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).

Authors:  Mark B Faries; John F Thompson; Alistair Cochran; Robert Elashoff; Edwin C Glass; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; He-Jing Wang; Donald L Morton
Journal:  Ann Surg Oncol       Date:  2010-07-08       Impact factor: 5.344

Review 4.  Elective lymph node dissection for melanoma: two perspectives.

Authors:  W H McCarthy; H M Shaw; N Cascinelli; M Santinami; F Belli
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

5.  Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.

Authors:  Surena F Matin; Janice N Cormier; John F Ward; Louis L Pisters; Christopher G Wood; Colin P N Dinney; Richard E Royal; Xuelin Huang; Curtis A Pettaway
Journal:  BJU Int       Date:  2013-04-02       Impact factor: 5.588

6.  A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes.

Authors:  Nicole Kounalakis; Dexiang Gao; Rene Gonzalez; Maude Becker; Karl Lewis; Jamie Poust; Nathan Pearlman; William Robinson; Martin McCarter
Journal:  Immunotherapy       Date:  2012-07       Impact factor: 4.196

7.  Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).

Authors:  Melinda M Mortenson; Yan Xing; Storm Weaver; Jeffrey E Lee; Jeffrey E Gershenwald; Anthony Lucci; Paul F Mansfield; Merrick I Ross; Janice N Cormier
Journal:  World J Surg Oncol       Date:  2008-06-18       Impact factor: 2.754

8.  Prevention of Secondary Lymphedema after Complete Lymph Node Dissection in Melanoma Patients: The Role of Preventive Multiple Lymphatic-Venous Anastomosis in Observational Era.

Authors:  Eleonora Nacchiero; Michele Maruccia; Fabio Robusto; Rossella Elia; Alessio Di Cosmo; Giuseppe Giudice
Journal:  Medicina (Kaunas)       Date:  2022-01-13       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.